RTI International, an independent, non-profit research institute, has completed the acquisition of Medical Data Analytics (MDA), a provider of real-world evidence generation to the pharmaceutical and biotechnology industry, it was reported on Monday.
The acquisition expands the RTI Health Solutions business unit's present services in design and conduct of observational research, with MDA's' capabilities in data collection and management, and physician and site recruitment. MDA is to operate as a separate business operation of RTI Health Solutions for a period of time. All MDA employees are likely to remain with the business following this transaction.
The terms of the transaction were not revealed.
GSK releases decade-long data on Shingrix efficacy
GSK announces positive EAGLE-1 results for gepotidacin in gonorrhoea treatment
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
Charles River Laboratories launches AMAP to reduce animal testing reliance
PureTech completes enrollment in Phase 2b ELEVATE IPF trial for LYT-100
Cybin secures additional US patent for CYB003 breakthrough therapy programme
UroGen's UGN-103 IND accepted by FDA for bladder cancer treatment
Biophytis reinforces obesity IP with new patent application
MaaT Pharma reveals positive 18-month data for MaaT013 in GI-aGvHD
Fusion Antibodies plc secures contract for OptiPhage library development
Innate Pharma advances Sanofi-developed NK cell engager to Phase 2 for blood cancer patients